article Open AccessTop 1% cited
Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials
Annals of Oncology · 2017 · Vol. 28(8) · pp. 1713–1729
Dirk Arnold(CUF Porto Hospital)B. Lueza(Université Paris-Sud)Jean-Yves Douillard(European Society for Medical Oncology)Marc Peeters(Antwerp University Hospital)Heinz‐Josef Lenz(USC Norris Comprehensive Cancer Center)Alan P. Venook(University of California, San Francisco)Volker HeinemannEric Van Cutsem(KU Leuven)Jean‐Pierre Pignon(Université Paris-Sud)Josep Tabernero(Universitat Autònoma de Barcelona)Andrés Cervantes(Universitat de València)Fortunato Ciardiello✉(University of Campania "Luigi Vanvitelli")
Colorectal Cancer Treatments and StudiesGenetic factors in colorectal cancerGastric Cancer Management and OutcomesMedicineInternal medicineKRASColorectal cancerHazard ratioOncologyBevacizumabChemotherapyChemotherapy regimenRandomized controlled trial
MeSH terms
BevacizumabCetuximabAntineoplastic Agents, ImmunologicalPanitumumabAntibodies, MonoclonalFemaleHumansMaleNeoplasm MetastasisPrognosisGenes, rasColorectal NeoplasmsRandomized Controlled Trials as TopicTreatment OutcomeErbB Receptors
Citations
819
FWCI
42.98
field-weighted impact
References
61
Percentile
100%
vs. same field & year
Citations per year
Cited by
Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Annals of Oncology · 2022 · 1,496 citations
References
Sex- and gender-specific disparities in colorectal cancer risk
World Journal of Gastroenterology · 2015 · 490 citations
The consensus molecular subtypes of colorectal cancer
Nature Medicine · 2015 · 5,121 citations
Are there two sides to colorectal cancer?
International Journal of Cancer · 2002 · 789 citations
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial
The Lancet Oncology · 2014 · 1,720 citations
Comparison of 17,641 Patients With Right- and Left-Sided Colon Cancer: Differences in Epidemiology, Perioperative Course, Histology, and Survival
Diseases of the Colon & Rectum · 2010 · 711 citations
Quantifying heterogeneity in a meta‐analysis
Statistics in Medicine · 2002 · 36,106 citations
Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor <i>KRAS</i> and <i>BRAF</i> Mutation Status
Journal of Clinical Oncology · 2011 · 1,880 citations
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
Annals of Oncology · 2016 · 3,389 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.